Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life...

Area of Science:

• Hematology
• Oncology
• Genomics

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a complex and heterogeneous lymphoid malignancy.
• Accurate subclassification of DLBCL is crucial for targeted therapy and prognosis.
• Recent advancements include algorithms for DLBCL subtyping based on molecular profiles.

Purpose of the Study:

• To compare the efficacy of two probabilistic algorithms, LymphGen and the Two-step classifier, in subclassifying DLBCL.
• To evaluate the subclassification rates and clinical relevance of identified DLBCL subtypes.

Main Methods:

• A cohort of 74 DLBCL cases was analyzed using immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and high-throughput sequencing (HTS).
• Cases were reclassified using the LymphGen and Two-step classifier algorithms based on genetic alterations.
• The performance of both algorithms was compared.

Main Results:

• The Two-step classifier achieved a 65.5% subclassification rate (36/55 cases), outperforming LymphGen's 20% rate (11/55 cases).
• Specific subtypes identified included BN2, EZB, MCD, N1, and ST2.
• The MCD subtype was associated with aggressive clinical behavior, including higher relapse and mortality rates.

Conclusions:

• The Two-step classifier demonstrates superior performance in subclassifying DLBCL based on genetic profiles.
• While promising, further improvements are necessary to enhance the classification rate and validate the clinical utility of these algorithms in routine diagnostics.